Visirna Therapeutics Hk Limited
Clinical trials sponsored by Visirna Therapeutics Hk Limited, explained in plain language.
-
New injection shows promise for rare High-Fat disease
Disease control CompletedThis phase 3 study tested a drug called Plozasiran in 37 Chinese adults with Familial Chylomicronemia Syndrome (FCS), a rare condition causing extremely high blood fats. The trial compared the drug to a placebo over about two years, measuring how much it lowered triglyceride leve…
Phase: PHASE3 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New cholesterol drug VSA003 passes first safety test in healthy volunteers
Disease control CompletedThis early-phase study tested a single dose of VSA003 in 36 healthy Chinese adults to see if it is safe and how the body handles it. The drug aims to help control high cholesterol and triglycerides. Participants received either VSA003 or a placebo, and researchers monitored for s…
Phase: PHASE1 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated Jun 26, 2026 15:39 UTC